ANAB – anaptysbio, inc. (US:NASDAQ)
Stock Stats
News
Actym Therapeutics Appoints Thomas Smart as CEO [Yahoo! Finance]
Actym Therapeutics Appoints Thomas Smart as CEO
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $47.00 price target on the stock.
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week [Yahoo! Finance]
Form ARS ANAPTYSBIO, INC For: Dec 31
Form DEFA14A ANAPTYSBIO, INC
Form DEF 14A ANAPTYSBIO, INC For: Jun 12
Form 4 ANAPTYSBIO, INC For: Mar 22 Filed by: Faga Daniel
Form S-8 ANAPTYSBIO, INC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.